Compare
Yubo International Biotech Ltd vs Hongchang International Co., Ltd vs ADM Tronics Unlimited, Inc. vs Neuraxis, Inc
| Latest fiscal year | Yubo International Biotech Ltd YBGJ | Hongchang International Co., Ltd HCILLast annual report: year ended 2024-12-31 | ADM Tronics Unlimited, Inc. ADMT | Neuraxis, Inc NRXS |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2024-12-31 | 2026-03-31 | 2025-12-31 |
| Revenue | $12.4K | $2.87M | $3.35M | $3.57M |
| Revenue growth (YoY) | +256.0% | +7.1% | +4.7% | +32.9% |
| Gross margin | 66.1% | 6.3% | 40.5% | 84.2% |
| Operating margin | n/m | -13.4% | -4.8% | -219.4% |
| Net margin | n/m | -16.5% | -3.0% | -218.5% |
| Net income | -$1.08M | -$472.4K | -$100.4K | -$7.80M |
| EPS (Diluted) | -$0.01 | $0.00 | $0.00 | -$0.95 |
| Operating cash flow | -$842.8K | -$7.34M | -$124.1K | -$6.43M |
| Free cash flow | n/a | -$11.36M | n/a | -$6.46M |
| Cash & equivalents | $8.1K | n/a | $255.7K | $4.97M |
| Total assets | $847.1K | $57.45M | $1.83M | $6.40M |
| Total liabilities | $2.79M | $18.68M | $1.26M | $3.00M |
| Shareholders' equity | -$1.95M | $38.77M | $571.0K | $3.40M |
| Return on year-end equity | n/a | -1.2% | -17.6% | -229.5% |
| Shares outstanding | n/a | 518.83M | 67.59M | 10.65M |
Revenue, most recent five fiscal years
| Fiscal year | Yubo International Biotech Ltd | Hongchang International Co., Ltd | ADM Tronics Unlimited, Inc. | Neuraxis, Inc |
|---|---|---|---|---|
| Latest | $12.4K Ended 2025-12-31 | $2.87M Ended 2024-12-31 | $3.35M Ended 2026-03-31 | $3.57M Ended 2025-12-31 |
| 1 year earlier | $3.5K Ended 2024-12-31 | $2.68M Ended 2023-12-31 | $3.20M Ended 2025-03-31 | $2.69M Ended 2024-12-31 |
| 2 years earlier | $604.7K Ended 2023-12-31 | $79.0K Ended 2022-12-31 | $2.97M Ended 2024-03-31 | $2.46M Ended 2023-12-31 |
| 3 years earlier | $104.3K Ended 2022-12-31 | $96.5K Ended 2021-12-31 | $3.68M Ended 2023-03-31 | $2.68M Ended 2022-12-31 |
| 4 years earlier | $1.24M Ended 2021-12-31 | $222.7K Ended 2020-12-31 | $3.21M Ended 2022-03-31 | n/a |